 |
| Vol. 2 Issue 02 Friday, January 18, 2008 |
Commercial Scale Antitubercular Pyrazinamide Isoniazid Rifampicin Antimalarial Artesunate Arteether Artemether Dihydroartemisinin Macrolides Azithromycin Erythromycin base Erythromycin estolate Erythromycin ethylsuccinate Erythromycin oxime (intermediate) Erythromycin phosphate Erythromycin propionate Erythromycin stearate Roxithromycin Antihypertensive Lisinopril dihydrate Losartan potassium Antiepileptic Sodium valproate Valproic acid Antiosteoporotic Alendronate sodium Zoledronic acid Sedative, Hypnotic Zopiclone Antidepressant Venlafaxine hydrochloride Antihistaminic Cetirizine dihydrochloride Antithrombotic Clopidogrel bisulphate Pilot Plant Scale Carvedilol Clarithromycin Pioglitazone hydrochloride Rosiglitazone maleate Valsartan R & D Scale Lumefantrine Pamidronate disodium Perindopril erbumine Zolpidem tartrate Development Benazepril hydrochloride Candesartan Desvenlafaxine Glipizide Irbesartan Levocetirizine Ramipril Rifabutin Rifapentine Risedronic acid Telmisartan
|
|
||||||||
|
|||||||||
|
|||||||||
| Disclaimer:
"The information in this e-mail and any attachments is confidential and may be legally privileged. It is intended solely for the addressee or addressees. If you are not an intended recipient, please delete the message and any attachments and notify the sender of misdelivery. Any use or disclosure of the contents of either is unauthorized and may be unlawful. All liability for viruses is excluded to the fullest extent permitted by law. Any views expressed in this message are those of the individual sender, except where the sender states them, with requisite authority, to be those of the specific Calyx company." |
|||||||||
| To unsubscribe from this Newsletter send blank email to pharmanews@calyxindia.com | |||||||||
| "Meet
us at ‘InformexUSA 2008’ at Morial Convention Centre,
New Orleans, Louisiana January 29 – February 1, 2008, at Booth 1707” |
|||||||||
 |